Cellular, Molecular and Biomedical Reports

Global Sciences

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Cellular, Molecular and Biomedical Reports is an open-access journal published by Global Sciences in France, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Global Sciences
ISSN
2823-2550
Country
France
Languages
english
Access
Open access
Articles in DOAJ
132
Declared review time
8 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2024-06-04
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
8 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

132

Most recent article

3 months ago

Average review time (journal-declared via DOAJ)

8weeks

Works in OpenAlex

125

Last recorded publication year

2025

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

22

i10-index

43

From OpenAlex open data (CC0).

Editorial & policy9
Last DOAJ review date
2024-06-04
Added to DOAJ
2024-06-04
Declared plagiarism screening
Declared
Other fees beyond APC
No
Editorial board
Official page ↗
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
Enrolled in Crossref Similarity Check
✓
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification2

Subjects (DOAJ)

Medicine

LCC codes

R

Subject areas

  • Antimicrobial Resistance in Staphylococcus
  • Antimicrobial Resistance in Staphylococcus
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • Bacterial Identification and Susceptibility Testing
  • Liver Disease Diagnosis and Treatment
  • Bacterial Identification and Susceptibility Testing
  • Liver Disease Diagnosis and Treatment
Show all subjects (50)
  • Circular RNAs in diseases
  • Malaria Research and Control
  • SARS-CoV-2 and COVID-19 Research
  • Hemoglobinopathies and Related Disorders
  • SARS-CoV-2 and COVID-19 Research
  • Hemoglobinopathies and Related Disorders
  • COVID-19 Clinical Research Studies
  • Diverse Scientific Research Studies
  • Malaria Research and Control
  • RNA modifications and cancer
  • Diverse Scientific Research Studies
  • Antibiotic Resistance in Bacteria
  • Antibiotic Resistance in Bacteria
  • Circular RNAs in diseases
  • RNA modifications and cancer
  • COVID-19 Clinical Research Studies
  • Epigenetics and DNA Methylation
  • RNA Interference and Gene Delivery
  • Ubiquitin and proteasome pathways
  • Nanoparticle-Based Drug Delivery
  • Ovarian function and disorders
  • Iron Metabolism and Disorders
  • RNA Interference and Gene Delivery
  • Epigenetics and DNA Methylation
  • Ubiquitin and proteasome pathways
  • Nanoparticle-Based Drug Delivery
  • Iron Metabolism and Disorders
  • Ovarian function and disorders
  • Computational Drug Discovery Methods
  • Nanoparticles: synthesis and applications
  • Reproductive Biology and Fertility
  • Reproductive Biology and Fertility
  • Pregnancy and preeclampsia studies
  • Tuberculosis Research and Epidemiology
  • Gut microbiota and health
  • Advanced biosensing and bioanalysis techniques
  • Pregnancy and preeclampsia studies
  • Tuberculosis Research and Epidemiology
  • Gut microbiota and health
  • Nanoparticles: synthesis and applications
  • Advanced biosensing and bioanalysis techniques
  • Computational Drug Discovery Methods

Keywords (DOAJ)

  • genetics and human genetic diseases
  • diabetes and molecular biology
  • cancer and biomolecular
  • biotechnology
  • medicinal plants

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: